Literature DB >> 33599919

Timing of treatment of aneurysmal subarachnoid haemorrhage: are the goals set in international guidelines achievable?

Abdurehman Choudhry1,2, Daniel Murray1, Paula Corr1, Deirdre Nolan1, Deirdre Coffey1, Stephen MacNally1, Alan O'Hare3, Sarah Power3, Matthew Crockett3, John Thornton3,2, Daniel Rawluk1, Paul Brennan3,2, Mohsen Javadpour4,5,6.   

Abstract

BACKGROUND AND AIMS: International guidelines emphasise the importance of securing ruptured cerebral aneurysms within 48-72 h of ictus. We assessed the timing of treatment of patients with aneurysmal subarachnoid haemorrhage (aSAH) referred to a national neurosurgical centre.
MATERIALS AND METHODS: Analysis of a prospective database of patients with aSAH admitted between 1st of February 2016 and 29th of February 2020 was performed. The timing to treatment was expressed in days and analysed in three ways: ictus to treatment, ictus to referral and referral to treatment. ORs with 95% CI were calculated for aneurysm treatment within 24, 48 and 72 h for good grade (WFSN 1-3) and poor grade (WFNS 4-5) cohorts separately.
RESULTS: Of a total of 538 patients with aSAH, the aneurysm was secured in 312 (58%) within 24 h and in 398 (74%) within 48 h of ictus. Securing the aneurysm within 48 h of ictus was achieved in 89% (395/444) of patients who were referred within 24 h of ictus, but in only 3.2% (3/94) who were referred > 24 h after ictus. Poor grade patients (WFNS 4-5) were more likely than good grade patients (WFNS 1-3) to be referred to neurosurgery within 48 h of ictus (OR 22.87, 95% CI 3.14-166.49, p = 0.0020) and for their aneurysm to be secured within 48 h (OR 1.78, 95% CI 1.06-2.98, p = 0.0297) of ictus. Ictus to referral delay was highest in WFNS grade 1 patients.
CONCLUSIONS: In centres with 7 day per week provision of interventional neuroradiology and vascular neurosurgery, the majority of patients with aSAH can be treated within the timeframes recommended by international guidelines and this applies to all grades of aSAH. However, delays still occur in a significant proportion of patients and this particularly applies to delays in presentation and diagnosis in good grade patients.
© 2021. Royal Academy of Medicine in Ireland.

Entities:  

Keywords:  Cerebral aneurysm; Guideline; Subarachnoid haemorrhage; Timing; Treatment

Mesh:

Year:  2021        PMID: 33599919     DOI: 10.1007/s11845-021-02542-1

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN: 0021-1265            Impact factor:   1.568


  17 in total

1.  Timing of aneurysm surgery in subarachnoid hemorrhage: a systematic review of the literature.

Authors:  Koen de Gans; Dennis J Nieuwkamp; Gabriël J E Rinkel; Ale Algra
Journal:  Neurosurgery       Date:  2002-02       Impact factor: 4.654

2.  Decreasing incidence of subarachnoid hemorrhage.

Authors:  Patrick Nicholson; Alan O'Hare; Sarah Power; Seamus Looby; Mohsen Javadpour; John Thornton; Paul Brennan
Journal:  J Neurointerv Surg       Date:  2018-10-12       Impact factor: 5.836

3.  Timing of aneurysm treatment after subarachnoid hemorrhage: relationship with delayed cerebral ischemia and poor outcome.

Authors:  Sanne M Dorhout Mees; Andrew J Molyneux; Richard S Kerr; Ale Algra; Gabriel J E Rinkel
Journal:  Stroke       Date:  2012-06-14       Impact factor: 7.914

4.  Predictors and impact of aneurysm rebleeding after subarachnoid hemorrhage.

Authors:  Andrew M Naidech; Nazli Janjua; Kurt T Kreiter; Noeleen D Ostapkovich; Brian-Fred Fitzsimmons; Augusto Parra; Christopher Commichau; E Sander Connolly; Stephan A Mayer
Journal:  Arch Neurol       Date:  2005-03

5.  Ultra-early (within 24 hours) aneurysm treatment after subarachnoid hemorrhage.

Authors:  George Kwok Chu Wong; Ronald Boet; Stephanie Chi Ping Ng; Matthew Chan; Tony Gin; Benny Zee; Wai Sang Poon
Journal:  World Neurosurg       Date:  2011-11-01       Impact factor: 2.104

6.  Guidelines for the management of aneurysmal subarachnoid hemorrhage: a guideline for healthcare professionals from the American Heart Association/american Stroke Association.

Authors:  E Sander Connolly; Alejandro A Rabinstein; J Ricardo Carhuapoma; Colin P Derdeyn; Jacques Dion; Randall T Higashida; Brian L Hoh; Catherine J Kirkness; Andrew M Naidech; Christopher S Ogilvy; Aman B Patel; B Gregory Thompson; Paul Vespa
Journal:  Stroke       Date:  2012-05-03       Impact factor: 7.914

7.  Incidence and significance of early aneurysmal rebleeding before neurosurgical or neurological management.

Authors:  H Ohkuma; H Tsurutani; S Suzuki
Journal:  Stroke       Date:  2001-05       Impact factor: 7.914

8.  Factors and outcomes associated with early and delayed aneurysm treatment in subarachnoid hemorrhage patients in the United States.

Authors:  Farhan Siddiq; Saqib A Chaudhry; Ramachandra P Tummala; M Fareed K Suri; Adnan I Qureshi
Journal:  Neurosurgery       Date:  2012-09       Impact factor: 4.654

9.  Comparison of the timing of intervention and treatment modality of poor-grade aneurysmal subarachnoid hemorrhage.

Authors:  Tomasz Tykocki; Marcin Czyż; Małgorzata Machaj; Dorota Szydlarska; Bogusław Kostkiewicz
Journal:  Br J Neurosurg       Date:  2017-04-24       Impact factor: 1.596

Review 10.  European Stroke Organization guidelines for the management of intracranial aneurysms and subarachnoid haemorrhage.

Authors:  Thorsten Steiner; Seppo Juvela; Andreas Unterberg; Carla Jung; Michael Forsting; Gabriel Rinkel
Journal:  Cerebrovasc Dis       Date:  2013-02-07       Impact factor: 2.762

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.